• HPR90 Sustainability of Biosimilars Medicines Policies in Brazil

    Jun 1, 2023, 00:00

  • RWD89 Risk of Electrolyte Imbalance in Elderly Colorectal Cancer Patients Following Treatment with Metformin Vs Sulfonylureas

    Jun 1, 2023, 00:00

  • EPH178 Disease Burden, Treatment Landscape, and Health Related Quality of Life Outcomes in Myasthenia Gravis: Results from the Adelphi Real World Disease Specific Programme in the United States and Europe

    Jun 1, 2023, 00:00

  • CO216 Understanding the Real-World Clinical Effectiveness of Pegcetacoplan for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

    Jun 1, 2023, 00:00

  • RWD11 Occurrence and Severity of Depression, Antidepressant Use Among Alzheimer’s Disease (AD) Patients across Race/Ethnicity

    Jun 1, 2023, 00:00

  • EE490 A Real-World Assessment of Healthcare Costs Related to Agitation Associated with Alzheimer's Dementia

    Jun 1, 2023, 00:00

  • PCR51 Qualitative Synthesis of Cognitive Debriefing and Usability Testing Studies to Inform Good Electronic Clinical Outcome Assessment Design

    Jun 1, 2023, 00:00

  • HPR97 Inpatient Policies and Requirements for the Reimbursement of Novel Therapies Outside the Drg in the US and EU5

    Jun 1, 2023, 00:00

  • PCR117 Meaningful Change Thresholds in Patient-Reported Outcome Scores for Patients with Colorectal Cancer – A Systematic Literature Review

    Jun 1, 2023, 00:00

  • PCR236 Impact of Clinical Features on Patient Reported Outcomes and Treatment Satisfaction in Psoriatic Arthritis

    Jun 1, 2023, 00:00

  • EPH101 Medication Adherence in Egypt: A Systematic Review

    Jun 1, 2023, 00:00

  • HPR157 Payer Perspectives on Health Insurance Coverage for Digital Therapeutics in the United States

    Jun 1, 2023, 00:00

  • MT30 Medtech Innovations in Oncology: A Review of NICE Medtech Innovation Briefings from 2014 to 2022

    Jun 1, 2023, 00:00

  • CO55 Psychometric Evaluation of the Measurement Properties of a Pediatric Clinical Outcome Assessment for Functional Constipation: Data from a Phase 3 Clinical Trial

    Jun 1, 2023, 00:00

  • MSR10 A Preliminary Assessment of Sample Size As a Search Strategy Filter on Embase.Com in Targeted Literature Searches

    Jun 1, 2023, 00:00

  • RWD117 Economic Impact of Depression Among Medicare Beneficiaries (AGE ≥65 YEARS) with Alzheimer’s Disease and Related Dementia (ADRD) in the United States (US)

    Jun 1, 2023, 00:00

  • EPH235 Impact of Pharmacist-Led Interventions on Medication-Related Outcomes Among Cancer Patients: A Systematic Review

    Jun 1, 2023, 00:00

  • EE543 The Impact of Different Utility Values on a Cost-Effectiveness Model in Diabetic Macular Edema

    Jun 1, 2023, 00:00

  • MT47 Does the Use of New Technology By Care Managers Have an Impact on Neonatal Intensive Care Unit (NICU) Admissions and Length of Stay?

    Jun 1, 2023, 00:00

  • P16 A Comparison of the Cox-Proportional Hazard Model and the Fine-Gray Model to Predict Survival in Patients with Non-Small Cell Lung Cancer (NSCLC)

    Jun 1, 2023, 00:00

  • EE365 Cost-Utility Analysis of Early Reconstruction Surgery Versus Rehabilitation and Delayed Reconstruction for Anterior Cruciate Ligament Tears in Low and Middle-Income Country

    Jun 1, 2023, 00:00

  • HSD56 Provider Perceptions Impacting Treatment Choice in Mantel Cell Lymphoma (MCL): An Analysis of the Shine Trial Evaluating Ibrutinib + Bendamustine and Rituximab (I+BR) Versus Bendamustine and Rituximab (BR) in First-Line (1L)

    Jun 1, 2023, 00:00

  • EPH41 Association of Ustekinumab with Carpal Tunnel Syndrome, Cutaneous Lupus Erythematosus, Basedow's Disease and Melanocytic Naevus: A Disproportionality Analysis in Usfda Adverse Event Reporting System Database

    Jun 1, 2023, 00:00

  • EE544 Budget Impact Analysis of Faricimab for Treating Patients with Diabetes Macular Edema or Neovascular Age-Related Macular Degeneration in Guatemala

    Jun 1, 2023, 00:00

  • CO208 Recurrence Rates and Survival Among Patients with Early-Stage Cancers: A Systematic Literature Review

    Jun 1, 2023, 00:00

  • P36 Navigating the Digital Health Landscape for Chronic Disease Management: A Value Assessment Framework for Patient-Facing Technologies

    Jun 1, 2023, 00:00

  • HPR58 A Tale of Two Drugs: How the Inflation Reduction Act of 2022 Impacts Drug Classes Differently

    Jun 1, 2023, 00:00

  • EE343 The Effect of BMI and the Obesity Paradox on Post-PCI Healthcare Costs and Length of Stay

    Jun 1, 2023, 00:00

  • EPH225 Understanding the Relationship between Depression and Suicidal Tendencies Among Tertiary Students in Ghana

    Jun 1, 2023, 00:00

  • CO11 Systematic Literature Review to Evaluate Randomized Clinical Trials of Advanced Therapies for Moderate to Severe Crohn's Disease

    Jun 1, 2023, 00:00

  • EPH38 Burden of Psychiatric Health in Elderly Myasthenia Gravis Patients: A Nationwide Medicare Perspective

    Jun 1, 2023, 00:00

  • HPR107 Landscape of Value-Based Contracting in Oncology

    Jun 1, 2023, 00:00

  • SA3 Characteristics of Patients Treated with CAR-T Therapies across Multiple Indications Utilizing the TriNetX Network

    Jun 1, 2023, 00:00

  • EE202 Cost-Effectiveness of Dolutegravir Versus Efavirenz-Based Combined Antiretroviral Regimens in HIV Infected Treatment-Naïve Patients at Nigeria’s University College Hospital.

    Jun 1, 2023, 00:00

  • EE162 Healthcare Resource Utilization and 2022 Cost Update of Cytokine Release Syndrome and Neurotoxicity in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Receiving Idecabtagene Vicleucel (IDE-CEL, BB2121) in KarMMa

    Jun 1, 2023, 00:00

  • SA43 Uptake of the Prisma 2020 Statement and Its Artificial Intelligence Component in Recently Published Systematic Reviews

    Jun 1, 2023, 00:00

  • EPH249 Development of Substance Use Disorder in Chronic Kidney Disease Patients Experiencing Uremic Pruritus

    Jun 1, 2023, 00:00

  • EPH109 Excess Mortality from Diabetes Mellitus in the First Year of the Pandemic in Colombia

    Jun 1, 2023, 00:00

  • EPH144 Exploring Variables Associated with Multimorbidity Status Among Older US Adults with Self-Reported Pain and Opioid Use

    Jun 1, 2023, 00:00

  • EE467 Prescription Patterns and Estimation of Cost of Illness of Type-II Diabetic Patients in a Tertiary Care Hospital Nepal

    Jun 1, 2023, 00:00

  • HPR121 Impact of Mandatory Prescription Drug Monitoring Program in Polysubstance-Related Admission Rate in the Substance Abuse Treatment Facilities in the United States

    Jun 1, 2023, 00:00

  • RWD45 Global Pricing Trends of Hepatitis C Medications

    Jun 1, 2023, 00:00

  • MSR44 Non-Randomized Studies in Comparative Effectiveness Research; How Systematically Are They Identified By Existing Search Filters? Results from a Systematic Literature Review

    Jun 1, 2023, 00:00

  • RWD152 Real-World Evidence on the Use of Ecmo in Hospitalized COVID-19 Patients: Results from a Linked Closed and Open Claims Database in the US

    Jun 1, 2023, 00:00

  • Disclosure Information

    Jun 1, 2023, 00:00

  • P52 Barriers to Reducing Time to Diagnosis and Treatment in Rare Disease

    Jun 1, 2023, 00:00

  • Epidemiology Public Health

    Jun 1, 2023, 00:00

  • CO139 A Retrospective Study of Sglt-2 Inhibitors Prescription Disparities and Affordability Among Medicare Patients with Diabetes

    Jun 1, 2023, 00:00

  • HPR20 Are We Ready for Reimbursement of Software As a Medical Device in Asia-Pacific (APAC) Region?

    Jun 1, 2023, 00:00

  • EE62 Healthcare Resource Utilization Among Patients with Transfusion-Dependent Beta-Thalassemia in Germany

    Jun 1, 2023, 00:00

  • RWD129 Work, Productivity, and Activity Impairment in Patients with Immunoglobulin a Nephropathy: Results from a Real-World Study

    Jun 1, 2023, 00:00

  • HTA88 A Systematic Literature Review of the Value of Prophylactic Treatment in Adult Patients with Hemophilia A

    Jun 1, 2023, 00:00

  • EE489 The Economic Burden of Caring for a Child with Duchene Muscular Dystrophy in Canada: A Caregiver Survey

    Jun 1, 2023, 00:00

  • EPH82 Racial Differences in Adverse Outcomes Following Androgen Deprivation Therapy for Prostate Cancer

    Jun 1, 2023, 00:00

  • P7 Racial and Ethnic Differences in the Use and Discontinuation of Long-Acting Injectable Antipsychotics

    Jun 1, 2023, 00:00

  • EE67 The Financial Impact of a Newly Introduced Thermosetting, Bioadhesive, Antibacterial Hydrogel to U.S. Commercial and Medicaid Insurers in Treating Bacterial Vaginosis

    Jun 1, 2023, 00:00

  • EE362 Systematic Review of Individual-Level Simulation in Cost-Effectiveness Analysis of Antiviral Treatments in Patients with Hepatitis B

    Jun 1, 2023, 00:00

  • HTA100 What Is a Good or Bad Number Needed to Treat (NNT)? A 2022 Updated Literature Review

    Jun 1, 2023, 00:00

  • PCR118 Quantifying Patient Preferences for Targeted Therapies in Metastatic Melanoma: A Discrete-Choice Experiment

    Jun 1, 2023, 00:00

  • CO70 Matching Adjusted Indirect Comparison (MAIC) of Single Tremelimumab Regular Interval Durvalumab (STRIDE) Versus Atezolizumab with Bevacizumab (A+B) for the Treatment of Unresectable Hepatocellular Carcinoma (UHCC)

    Jun 1, 2023, 00:00

  • EE436 Cystic Fibrosis Treatment Costs in a Brazilian Health Insurance Company

    Jun 1, 2023, 00:00

  • EE351 Comparing Real-Time Continuous Glucose Monitoring with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes on Insulin Therapy: A Cost-Utility Study

    Jun 1, 2023, 00:00

  • EE12 Diagnosing Irritable Bowel Syndrome (IBS): A Real-World Study to Assess Resource Utilization

    Jun 1, 2023, 00:00

  • EE300 Clinical and Economic Burden of Exacerbations in Patients with Severe Asthma in South Korea

    Jun 1, 2023, 00:00

  • EE439 Prevention of Needlestick Injuries and Blood Exposures Among Kenyan Healthcare Workers Using Safety Engineered Devices

    Jun 1, 2023, 00:00

  • EE321 Cost Impact of Next Generation Sequencing Testing in NSCLC with and without RNA Sequencing

    Jun 1, 2023, 00:00

  • EE528 Healthcare Resource Utilization Among Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in England

    Jun 1, 2023, 00:00

  • EPH84 Administrative Claims-Based Algorithm to Identify Patients with Primary Sclerosing Cholangitis

    Jun 1, 2023, 00:00

  • HPR53 Uncovering Prescription Drug Pricing: Insights from Payer Price Transparency Regulations

    Jun 1, 2023, 00:00

  • P11 Depression Severity Among Patients with Psychiatric Disorders during the COVID-19 Pandemic

    Jun 1, 2023, 00:00

  • EE217 Efficiency-Equity Trade-Offs in Cost-Effectiveness Analyses: An Umbrella Review of Previous Systematic Literature Reviews

    Jun 1, 2023, 00:00

  • MT46 Real World Use of Circulating Tumor DNA (CTDNA) in Colorectal Cancer (CRC): A Targeted Literature Review (TLR)

    Jun 1, 2023, 00:00

  • HTA60 Potential Decision Drivers for Positive Recommendations of New Cancer Therapies in the Brazilian Private Healthcare System: Analysis of Recent HTA Submissions

    Jun 1, 2023, 00:00

  • EE315 Trends in Medical Expenditure and Resource Utilization Among Opioid, Benzodiazepine, Skeletal Muscle Relaxant, and Gabapentin Users: A Pooled Cross Sectional Analysis from 2009 - 2019

    Jun 1, 2023, 00:00

  • P20 An Evaluation of Special Considerations in the Assessment and Decision-Making Processes across HTA Agencies for Drugs for Rare Diseases

    Jun 1, 2023, 00:00

  • PCR172 Communicating Challenging Concepts in Preference Research: Developing and Testing a Discrete Choice Experiment (DCE) Survey in Metastatic Castration-Resistant Prostate Cancer (MCRPC)

    Jun 1, 2023, 00:00

  • SA10 Benchmarking of Budget Impact Results: An Updated Systematic Review of US Budget Impact Analyses

    Jun 1, 2023, 00:00

  • EPH182 Disparities in Early Diagnosis, Treatment, and Survival Outcomes Among Patients with Early-Onset Colorectal Cancer in Texas

    Jun 1, 2023, 00:00

  • EE306 The Burden of Disease of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration in Costa Rica

    Jun 1, 2023, 00:00

  • EE68 Cost-Effectiveness of Using a Novel Machine Learning Algorithm to Diagnose Idiopathic Pulmonary Fibrosis

    Jun 1, 2023, 00:00

  • EPH114 Willingness to Use Prep Among Prep Naïve Men Who Have Sex with Men: A Meta-Analysis and Systematic Review

    Jun 1, 2023, 00:00

  • PCR187 Patient and Physician Satisfaction of Treatment with Eculizumab or Ravulizumab in Paroxysmal Nocturnal Hemoglobinuria: Results from a Real-World Disease-Specific Programme

    Jun 1, 2023, 00:00

  • CO226 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Multiple Myeloma in the US: Real-World Evaluation of Patient Characteristics and Treatment Patterns

    Jun 1, 2023, 00:00

  • HPR105 Impact of Social Determinants of Health on Access to Device Aided Therapy Services for Medicare Fee-for-Service Beneficiaries with Advanced Parkinsons Disease

    Jun 1, 2023, 00:00

  • HPR110 Risk Factors Associated with Repeat Pediatric Asthma Visits to Emergency Departments

    Jun 1, 2023, 00:00

  • PCR35 Asthma Management Support Needs Among Young Adults: A Pilot Qualitative Study

    Jun 1, 2023, 00:00

  • EPH257 Public Health Impact of UK COVID-19 Booster Vaccination during Omicron Predominance

    Jun 1, 2023, 00:00

  • EPH90 Incidence Rate of Infections and Association between Lupus Nephritis and Serious Infections in Patients with Systemic Lupus Erythematosus: Systematic Literature Review and Meta-Analyses

    Jun 1, 2023, 00:00

  • MSR73 Bayesian Hierarchical Models for Indirect Treatment Comparisons of Histology-Independent Therapies for Survival Outcomes

    Jun 1, 2023, 00:00

  • HPR82 How Has Commercial Coverage of Specialty Drugs Changed over Time?

    Jun 1, 2023, 00:00

  • MT49 Watch on the Dash – A CEA Tool of LAAC for Atrial Fibrillation in the Brazilian Healthcare System

    Jun 1, 2023, 00:00

  • MT15 Adherence to Positive Airway Pressure Therapy in a Cohort of Colombian Patients with Obstructive Sleep Apnea Syndrome

    Jun 1, 2023, 00:00

  • EPH107 Impact of Different Non-Invasive Tests on Estimated Prevalence of Presumed Nonalcoholic Steatohepatitis Among US Adults, NHANES 2017-2020

    Jun 1, 2023, 00:00

  • CO151 Impact of the Rational Antibiotic Use System on Hospital Performance at Cartagena Colombia from 2018 to 2021

    Jun 1, 2023, 00:00

  • RWD43 Comparison of All-Cause Healthcare Resource Utilization Rates between Patients with Type 2 Diabetes Who Use a Digital Diabetes Solution Versus Non-Users: A 12-Month Retrospective Cohort Study

    Jun 1, 2023, 00:00

  • Award Winners

    Jun 1, 2023, 00:00

  • EE531 Evidence Generation Planning for and Economic Modeling of Rare Progressive Pediatric Diseases: Challenges and Prospective Solutions

    Jun 1, 2023, 00:00

  • CO170 Baseline Characteristics, Including Hospitalizations, of Asthma Patients Treated with Dupilumab in the Real World: The Rapid Registry

    Jun 1, 2023, 00:00

  • Clinical Outcomes

    Jun 1, 2023, 00:00

  • MSR36 How Does the Use of Different Targeted Literature Review (TLR) Methodologies Impact the Research Output? a Case Study of Structured Vs. Focused Vs. Pearl Growing Approach

    Jun 1, 2023, 00:00

  • PCR196 Designing Fit-for-Purpose Patient Preference Studies - A COA Developer Perspective

    Jun 1, 2023, 00:00

  • EE74 The Burden of Disease of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration in Panama

    Jun 1, 2023, 00:00

  • HPR102 Exploring the Cost of Managing Diabetes in Nepal: A Cross-Sectional Analysis of Oral Hypoglycemic Medications

    Jun 1, 2023, 00:00

  • HPR25 An Assessment of Value-Based Health Care Elements in Colombia

    Jun 1, 2023, 00:00

  • EE155 Burden of Illness of Adult Patients with Metastatic Colorectal Cancer Bearing the KRAS P.G12C Mutation - A Systematic Literature Review

    Jun 1, 2023, 00:00

  • RWD64 Reduction of Biologic Pricing Following Biosimilar Introduction

    Jun 1, 2023, 00:00

  • EE295 Patient Financial Burden Following Discontinuation of Oral Pharmacotherapy: An Analysis of Treatment Options for Men with Erectile Dysfunction

    Jun 1, 2023, 00:00

  • RWD20 Analysis of US Real World Evidence Data to Assess and Compare the Effectiveness of Two Chemotherapy Regimens: FOLFIRINOX Vs Gemcitabine/Nab-paclitaxel for First Line Metastatic Pancreatic Cancer

    Jun 1, 2023, 00:00

  • HPR87 Patient Assistance Programs for Genetic Testing: Closing the Underinsurance Gap or Widening Disparities?

    Jun 1, 2023, 00:00

  • EPH93 Traceability of Infliximab Reference Medicinal Product and Its Biosimilar Products Adverse Drug Events Reports in Saudi Arabia

    Jun 1, 2023, 00:00

  • EPH200 Sociodemographic and Clinical Characteristics of Patients with Alopecia Areata in Colombia: Data from the First National Registry

    Jun 1, 2023, 00:00

  • HTA11 Challenges in Establishing a National Health Technology Assessment Agency in the United States: Insight from Low- and Middle-Income Countries

    Jun 1, 2023, 00:00

  • HSD64 Biologics Vs. Biosimilars Utilization Among Rheumatoid Arthritis (RA) Patients

    Jun 1, 2023, 00:00

  • MT26 Evaluating the Impact of Digital Proms Collection in an Outpatient Breast Cancer Clinic: A Feasibility Pilot

    Jun 1, 2023, 00:00

  • EPH89 Analysis of the Effect of Healthy Migrant on Chronic Diseases and Its Associated Social Determinants of Health

    Jun 1, 2023, 00:00

  • MSR30 Comparison of Search Design and Output of Embase Using Two Different Search Interfaces: Embase.com and OVID

    Jun 1, 2023, 00:00

  • MSR87 Reviewing Elements to Inform Re-Running Searches: Refreshing Systematic Literature Reviews

    Jun 1, 2023, 00:00

  • EE86 Cost-Effectiveness Analysis of Axicabtagene Ciloleucel, Lisocabtagene Maraleucel, and Tisagenlecleucel CAR T-Cell Therapies for Treatment of Relapsed or Refractory Large B-Cell Lymphoma (LBCL)

    Jun 1, 2023, 00:00

  • RWD156 The Impact of the Sars-Cov-2 Pandemic (COVID-19) on the Incidence of Newly Diagnosed Multiple Myeloma Patients Using a Federated Network of Real-World Evidence in US and Germany

    Jun 1, 2023, 00:00

  • PCR216 Insights from Social Media Posts on the Lived Experience of Alzheimer's Disease

    Jun 1, 2023, 00:00

  • HTA59 Anticipating Market Access Challenges in Canada for Lecanemab: Learnings from Previous Health Technology Assessments of Disease-Modifying Therapies in Neurodegenerative Diseases

    Jun 1, 2023, 00:00

  • EPH17 Prevalence of Perinatal Depression Among Rural Women in Yunnan Province, China: A Population-Based Screening Programme

    Jun 1, 2023, 00:00

  • SA49 Virological Suppression in People Living with HIV-1 (PLWH) Receiving Dolutegravir/Lamivudine Was High and Similar across Age Groups Despite Older Plwh Having Increased Rates of Comorbidities and Polypharmacy (TANDEM SUBGROUP)

    Jun 1, 2023, 00:00

  • CO35 Real-World Effectiveness of Intravitreal Ranibizumab and Aflibercept for Eyes with Central Retinal Vein Occlusion: A Multi-Institutional Cohort Study in Taiwan

    Jun 1, 2023, 00:00

  • EE171 Time to Diagnosis and Cost Effectiveness of Whole Exome Sequencing (WES) Position in the Diagnostic Pathways of Patients with Suspected Rare Genetic Disease

    Jun 1, 2023, 00:00

  • EE19 Cost-Effectiveness Analysis of Nonpharmaceutical Interventions Combined with Inactivated Vaccination and Oral Medicine in China

    Jun 1, 2023, 00:00

  • EPH174 Trends in Postpartum Depression before and during the COVID-19 Pandemic and Correlates of Treatment Choices: A Population-Based Retrospective Cohort Study

    Jun 1, 2023, 00:00

  • HSD23 Comparison of Drug Utilization Outcomes of Direct Oral Anticoagulants in Medicare Patients

    Jun 1, 2023, 00:00

  • EE17 Societal Cost of Racial Disparities in Pneumococcal Disease in U.S. Adults Aged 50 Years or Older

    Jun 1, 2023, 00:00

  • PCR141 What Drives the Views of Young People (16–23 YEARS) and Parents on Invasive Meningococcal Disease and Their Willingness to Vaccinate?

    Jun 1, 2023, 00:00

  • CO25 Impact of Novel Anti-Tumor Therapies on Mortality in Various Oncology Indications across EU5

    Jun 1, 2023, 00:00

  • HPR47 Access to Prenatal Care and Poverty in Colombian Regions: Before and in the Pandemic

    Jun 1, 2023, 00:00

  • EE139 Cost-Effectiveness of Aducanumab Versus Donepezil for Patients with Early Alzheimer's Disease

    Jun 1, 2023, 00:00

  • EE177 Topical Sirolimus 0.2% Gel for Treatment of Facial Angiofibroma Associated with Tuberous Sclerosis Complex in the United States: A Budget Impact Analysis

    Jun 1, 2023, 00:00

  • EE553 Estimating the Economic Burden of Progressive Multifocal Leukoencephalopathy in the United States: A Literature Review and Assessment

    Jun 1, 2023, 00:00

  • CO39 Real-World Assessment of Efficacy and Safety of Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: Systematic Review and Meta-Analysis

    Jun 1, 2023, 00:00

  • HPR5 Minimally Invasive Thyroidectomy Implementation for Cancer Care: Do Racial, Ethnic and Insurance Characteristics Play a Role?

    Jun 1, 2023, 00:00

  • MT44 A Systematic Literature Review and Meta-Analysis of Randomized Controlled Trials Comparing Robotic Assisted Cancer Surgery with the Laparoscopic or Open Approach

    Jun 1, 2023, 00:00

  • EE367 Cost-Effectiveness Analysis of Different Treatment Strategies for Schizophrenia in China

    Jun 1, 2023, 00:00

  • HTA28 Evaluation of the Cost-Effectiveness of Laparoscopic Partial Nephrectomy in Comparison with Open Partial Nephrectomy

    Jun 1, 2023, 00:00

  • MSR81 Vaccine Rate Coverage Forecast in Brazil: Is It Possible to Keep Polio Eradicated?

    Jun 1, 2023, 00:00

  • HPR63 A Sneak Peek at the Medicare Part D Drugs Likely to be Targeted By CMS for Price Negotiation: Prediction Using Medicare Claims Data

    Jun 1, 2023, 00:00

  • HSD39 Demodex Blepharitis Patient Journey: A Medical Chart Audit Study

    Jun 1, 2023, 00:00

  • EE381 Cost-Effectiveness Analysis of Active Surveillance Compared to Early Surgery in Small Papillary Thyroid Cancer with the Previous Data in Korean Population

    Jun 1, 2023, 00:00

  • PCR249 Advancing Equity, Diversity, Inclusion, and Belonging in Patient Centered Drug Development with Patient Preference Research

    Jun 1, 2023, 00:00

  • EE452 The Economic Impact on the Introduction of the Antidote N-Acetylcysteine in the Management of Acute Paracetamol Intoxication in Algeria

    Jun 1, 2023, 00:00

  • EPH125 Association of Sarcopenia with Functional Limitations and Caregiver Burden Among Chinese Elderly

    Jun 1, 2023, 00:00

  • SA28 Review of Machine Learning Based Disease Diagnosis Modeling

    Jun 1, 2023, 00:00

  • EE331 Leveraging Time-Use Data to Estimate Market and Non-Market Productivity Losses Due to Respiratory Syncytial Virus (RSV) Disease Among Adults Aged ≥60 Years in the United States (US)

    Jun 1, 2023, 00:00

  • PCR119 The Impacts of Age and Gender on Mapped EQ-5D-5L Utilities and Quality-Adjusted Life Years (QALYS) in Cancer Clinical Trials

    Jun 1, 2023, 00:00

  • RWD140 Economic Burden of Post-ERCP Pancreatitis in Inpatient Setting Among Elderly Beneficiaries Enrolled in Traditional Medicare

    Jun 1, 2023, 00:00

  • HSD22 Understanding Barriers and Facilitators to Prescribing Sodium-Glucose Trasnporter-2 Inhibitors in Patients with Heart Failure with Reduced Ejection Fraction

    Jun 1, 2023, 00:00

  • EE382 Healthcare Expenditure Burden of Melanoma in the Era of Immune Checkpoint Inhibitors

    Jun 1, 2023, 00:00

  • MT11 Field Testing of a Novel Holistic National Health Outcome Score: An Indicator of Health from Patient-Reported Outcomes

    Jun 1, 2023, 00:00

  • HPR161 International Comparisons of Health Technology Assessment and Reimbursement Outcomes for Oncology Drugs with Regulatory Review through Project Orbis

    Jun 1, 2023, 00:00

  • EE477 Cost Evaluation of a Nurse Coordinated Outpatient Parenteral Antimicrobial Therapy (OPAT) Program

    Jun 1, 2023, 00:00

  • MT50 Value Stream Mapping and Analysis of the Quality Parameters from the Control Units Processed Using a Semi-Automated, Buffy Coat Method, in a Colombian Blood Bank Center

    Jun 1, 2023, 00:00

  • EE383 Cost-Utility and Value of Information Analysis of Novel Treatments for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

    Jun 1, 2023, 00:00

  • EE312 Cost-Effectiveness Analysis of the Transobturator Tape Compared to the Tension-Free Vaginal Tape Technique in the Correction of Patients with Stress Urinary Incontinence in an Institution of Medellín – Colombia

    Jun 1, 2023, 00:00

  • RWD107 Identification and Evaluation of Congenital Anomaly Safety Signals: SFDA Experience

    Jun 1, 2023, 00:00

  • CO175 Acute Kidney Injury from Intravitreal Anti–Vascular Endothelial Growth Factor Drugs: A Systematic Review and Meta-Analysis

    Jun 1, 2023, 00:00

  • EPH184 Prevalence of Acute Myeloid Leukemia in the United States: A Cross-Sectional Study Using the SEER Database

    Jun 1, 2023, 00:00

  • RWD61 Comparison of Healthcare Costs for Women with Treated Vs Untreated Vasomotor Symptoms Associated with Menopause

    Jun 1, 2023, 00:00

  • CO42 Identifying a Relationship between Preoperative Albumin Levels and Postoperative Outcomes in Joint Arthroplasty: Real-World Evidence

    Jun 1, 2023, 00:00

  • HPR3 Why the Increase? Drilling Down on Increases in Prescribed Medication Expenditures in the United States between 2011 and 2020: Findings from the Medical Expenditures Panel Survey

    Jun 1, 2023, 00:00

  • RWD80 Use of Ml Model to Predict Biologic to Biosimilar Switch in Inflammatory Bowel Disease

    Jun 1, 2023, 00:00

  • OP5 Cost-Shifting Practices in Hospitals: A Systematic Review

    Jun 1, 2023, 00:00

  • PCR247 Relation of Patient Activation to Medication Adherence in Low-Literacy Older Adults with Chronic Health Conditions

    Jun 1, 2023, 00:00

  • CO45 Durability of Efficacy and Safety of Roflumilast Cream 0.3% in Adults with Chronic Plaque Psoriasis from a 52-Week, Phase 2 Open-Label Safety Trial

    Jun 1, 2023, 00:00

  • MSR46 ADTs Drive Real-Time Readmission Prediction for Blue Cross and Blue Shield of Louisiana Members: A Model Evaluation

    Jun 1, 2023, 00:00

  • OP10 Safety Monitoring of Orphan Drugs Project: SFDA Experience

    Jun 1, 2023, 00:00

  • SA11 Evaluating the Adherence to ISPOR Guidelines in US Published Budget Impact Analyses of New Drugs: A Targeted Literature Review

    Jun 1, 2023, 00:00

  • PCR93 Effect of Physicians’ Prescribing Choices of First- or Second-Line Tumor Necrosis Factor Inhibitor Biologics Versus Non-Tumor Necrosis Factor Inhibitor Biologic Therapies on Psoriatic Arthritis Patient-Reported Outcomes

    Jun 1, 2023, 00:00

  • CO210 Real-World Effectiveness and Treatment Patterns of Venetoclax-Based Regimens Among Patients with Chronic Lymphocytic Leukemia (CLL) Treated in Community Settings

    Jun 1, 2023, 00:00

  • RWD38 Quality of Electronic Health Records: Managing Aggregated Patient Demographic Information

    Jun 1, 2023, 00:00

  • EE326 Malnutrition Prevalence and Economic Burden Among US Hospitalized Older Adult Patients with and without COVID-19

    Jun 1, 2023, 00:00

  • MT52 Real World Utilization of Digital Therapeutics: A Review

    Jun 1, 2023, 00:00

  • PCR221 Measurement and Analysis of Health-Related Quality of Life Data in Cancer Drug Trials: A Review of Post-Reimbursement Data

    Jun 1, 2023, 00:00

  • EE88 Cost-Effectiveness Analysis of Etodolac and Aceclofenac in Low Back Pain

    Jun 1, 2023, 00:00

  • EPH242 Adherence and Factors Associated with Cotrimoxazole Preventive Therapy Among Adult Human Immunodeficiency Virus (HIV) Patients Attending Antiretroviral Clinics in Jigjiga Hospitals

    Jun 1, 2023, 00:00

  • P50 Using Biomarker Change and Treatment Adherence to Predict Risk of Relapse Among Chronic Myeloid Leukemia Patients Who Are in Remission

    Jun 1, 2023, 00:00

  • PCR166 PRO Reporting and Methodological Rigor in NSCLC RCTs, a Cause for Concern

    Jun 1, 2023, 00:00

  • HPR70 Therapeutic Preference for Alzheimer’S Disease Treatments: A Discrete Choice Experiment (DCE) with Caregivers and Neurologists

    Jun 1, 2023, 00:00

  • EPH230 Estimating Risk of Disease Progression from Mild Cognitive Impairment (MCI) to Alzheimer’s Disease (AD) Using Administrative Claims

    Jun 1, 2023, 00:00

  • HPR120 The Pan-Canadian Tiered Pricing Framework and Chinese National Volume-Based Procurement: A Comparative Study Using Donabedian's Structure-Process-Outcome Framework

    Jun 1, 2023, 00:00

  • EE30 Annual Disability-State Transition Probabilities Estimated from a Large Sample (>6000) of Australians with Multiple Sclerosis from MS-Base

    Jun 1, 2023, 00:00

  • EE58 Healthcare Resource Utilization Among Patients with Transfusion-Dependent Beta-Thalassemia in Italy

    Jun 1, 2023, 00:00

  • RWD19 Comparative Effectiveness Using External Controls for Single-Arm Trials of Pembrolizumab in Tumor-Agnostic Indications Leveraging Real-World Data

    Jun 1, 2023, 00:00

  • HPR129 Is Cost-Effectiveness Analysis a Tool to Exercise Value-Based Pricing or Monopsony Power? Evidence from Canada and Other Countries

    Jun 1, 2023, 00:00

  • HTA26 Duration and Timing of Treatment Waning: Determining the Start and Stop Points Using Pembrolizumab in NSCLC As a Case Study

    Jun 1, 2023, 00:00

  • Editorial Board

    May 1, 2023, 08:40

  • Caregiving-Related Work Productivity Loss Among Employed Family and Other Unpaid Caregivers of Older Adults

    May 1, 2023, 00:00

  • Comparability Among Modes of Data Collection for Patient-Reported Outcome Measures: Opening the Gates for Faithful Migration

    May 1, 2023, 00:00

  • Economic Evaluation of Elective Cesarean Section on Maternal Request Compared With Planned Vaginal Birth—Application to Swedish Setting Using National Registry Data

    May 1, 2023, 00:00

  • The European Organisation for Research and Treatment of Cancer Quality of Life Utility-Core 10 Dimensions: Development and Investigation of General Population Utility Norms for Canada, France, Germany, Italy, Poland, and the United Kingdom

    May 1, 2023, 00:00

  • Cost-Effectiveness of Medication Therapy Management Program Across Racial and Ethnic Groups Among Medicare Beneficiaries [Editor's Choice]

    May 1, 2023, 00:00

  • Twenty-Five Years of Health Economics and Outcomes Research: An Exploration of Value in Health

    May 1, 2023, 00:00

  • Health and Economic Evaluation of Vaccination Against Pertussis in China: A 40-Year Analysis

    May 1, 2023, 00:00

  • Economic Evaluation of Family-Focused Programs When Parents Have a Mental Health Problem: Methodological Considerations

    May 1, 2023, 00:00

  • Table of Contents

    May 1, 2023, 00:00

  • Copyright/Subscription

    May 1, 2023, 00:00

  • Developing Prioritization Criteria to Identify Target Drugs for CalRx, the California Generic Drugs Initiative

    May 1, 2023, 00:00

  • The Impact of Reimbursement for Non-Face-to-Face Chronic Care Management on Health Utilization Among Patients With Type 2 Diabetes in Louisiana

    May 1, 2023, 00:00

  • The Cost-Effectiveness of Financial Incentives to Achieve Heroin Abstinence in Individuals With Heroin Use Disorder Starting New Treatment Episodes: A Cluster Randomized Trial-Based Economic Evaluation

    May 1, 2023, 00:00

  • Censoring Time Trade-off Values at 0 Versus at −1: How Does the Assumption for Worse-Than-Dead Time Trade-off Values Affect the Modeling of EQ-5D-5L Valuation Data?

    May 1, 2023, 00:00

  • EQ-5D-3L Norms for the European Older Population: Country-Specific Norms for 15 European Countires Based on the Survey of Health, Ageing, and Retirement in Europe

    May 1, 2023, 00:00

  • Comparisons in the Health and Economic Assessments of Using Quadrivalent Versus Trivalent Influenza Vaccines: A Systematic Literature Review

    May 1, 2023, 00:00

  • Updated Recommendations on Evidence Needed to Support Measurement Comparability Among Modes of Data Collection for Patient-Reported Outcome Measures: A Good Practices Report of an ISPOR Task Force

    May 1, 2023, 00:00

  • Dealing With Uncertainty in Early Health Technology Assessment: An Exploration of Methods for Decision Making Under Deep Uncertainty [Editor's Choice]

    May 1, 2023, 00:00

  • Do Misconceptions About Health-Related Quality of Life Affect General Population Valuations of Health States? [Editor's Choice]

    May 1, 2023, 00:00

  • Estimating Joint Health State Utility Algorithms Under Partial Information

    May 1, 2023, 00:00

  • Assessing Outcomes for Cost-Utility Analysis in Children and Adolescents With Mental Health Problems: Are Multiattribute Utility Instruments Fit for Purpose?

    May 1, 2023, 00:00

  • The Use of Multicriteria Decision Analysis to Support Decision Making in Healthcare: An Updated Systematic Literature Review [Editor's Choice]

    May 1, 2023, 00:00

  • Editorial Board

    Apr 20, 2023, 10:47

  • Editorial Board

    Apr 2, 2023, 08:18

  • Table of Contents

    Apr 1, 2023, 00:00

  • Reducing Hospital Capacity Needs for Seasonal Respiratory Infections: The Case of Switching to High-Dose Influenza Vaccine for Dutch Older Adults

    Apr 1, 2023, 00:00

  • Table of Contents

    Apr 1, 2023, 00:00

  • Structure and Content of a Taxonomy to Support the Use of Real-World Evidence by Health Technology Assessment Practitioners and Healthcare Decision Makers

    Apr 1, 2023, 00:00

  • Cost-Effectiveness of Venetoclax Plus Obinutuzumab Versus Chlorambucil Plus Obinutuzumab for the First-Line Treatment of Adult Patients With Chronic Lymphocytic Leukemia: An Extended Societal View

    Apr 1, 2023, 00:00

  • Data Governance for Real-World Data Management: A Proposal for a Checklist to Support Decision Making

    Apr 1, 2023, 00:00

  • EUreccA 2025: A Multistakeholder Effort to Further Real-World Evidence in Healthcare Decision Making

    Apr 1, 2023, 00:00

  • Reviewer Acknowledgment

    Apr 1, 2023, 00:00

  • Development of the Cystic Fibrosis Questionnaire-Revised-8 Dimensions: Estimating Utilities From the Cystic Fibrosis Questionnaire-Revised [EDITOR'S CHOICE]

    Apr 1, 2023, 00:00

  • A Conceptual Framework for Life-Cycle Health Technology Assessment

    Apr 1, 2023, 00:00

  • Using Real-World Data in the Health Technology Assessment of Pharmaceuticals: Strengths, Difficulties, and a Pragmatic Way Forward

    Apr 1, 2023, 00:00

  • Approaches to the Assessment of Clinical Benefit of Treatments for Conditions That Have Heterogeneous Symptoms and Impacts: Potential Applications in Rare Disease

    Apr 1, 2023, 00:00

  • Copyright/Subscription

    Apr 1, 2023, 00:00

  • Pneumococcal Vaccination in Children: A Systematic Review and Meta-Analysis of Cost-Effectiveness Studies

    Apr 1, 2023, 00:00

  • An Analysis of Accessibility of Representative Psychotropic Medicine From the World Health Organization Model List of Essential Medicines in Developing Countries With Different Income Levels

    Apr 1, 2023, 00:00

  • Across-Country Variations of Real-World Data and Evidence for Drugs: A 5-European-Country Study

    Apr 1, 2023, 00:00

  • Author Reply

    Apr 1, 2023, 00:00

  • Lost Therapeutic Benefit of Delayed Low-Density Lipoprotein Cholesterol Control in Statin-Treated Patients and Cost-Effectiveness Analysis of Lipid-Lowering Intensification

    Apr 1, 2023, 00:00

  • The Real-World Evidence Workstream in EUreccA 2025: How the Task Was Addressed

    Apr 1, 2023, 00:00

  • Cost-Effectiveness of Tepotinib Versus Capmatinib for the Treatment of Adult Patients With Metastatic Non–Small Cell Lung Cancer Harboring Mesenchymal–Epithelial Transition Exon 14 Skipping

    Apr 1, 2023, 00:00

  • Interaction Effects in Health State Valuation Studies: An Optimal Scaling Approach

    Apr 1, 2023, 00:00

  • Mapping Studies to Estimate Health-State Utilities From Nonpreference-Based Outcome Measures: A Systematic Review on How Repeated Measurements are Taken Into Account [EDITOR'S CHOICE]

    Apr 1, 2023, 00:00

  • Suitability of Preference Methods Across the Medical Product Lifecycle: A Multicriteria Decision Analysis

    Apr 1, 2023, 00:00

  • Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task Force [EDITOR'S CHOICE]

    Apr 1, 2023, 00:00

  • A Comparison of Alternative Network Meta-Analysis Methods in the Presence of Nonproportional Hazards: A Case Study in First-Line Advanced or Metastatic Renal Cell Carcinoma

    Apr 1, 2023, 00:00

  • Between-Hospital and Between-Physician Variation in Outcomes and Costs in High- and Low-Complex Surgery: A Nationwide Multilevel Analysis

    Apr 1, 2023, 00:00

  • Illustrating Emerging Good Practices for Quantitative Benefit-Risk Assessment: A Hypothetical Case Study of Systemic Biologic Treatments for Plaque Psoriasis

    Apr 1, 2023, 00:00

  • Emerging Good Practices for Quantitative Benefit-Risk Assessment: A Step Forward [EDITOR'S CHOICE]

    Apr 1, 2023, 00:00

  • Cost-Effectiveness of Respiratory Syncytial Virus Preventive Interventions in Children: A Model Comparison Study

    Apr 1, 2023, 00:00

  • Editorial Board

    Mar 2, 2023, 08:26

  • The Value of Medical Innovation Versus Industry Rewards

    Mar 1, 2023, 00:00

  • Equitable Prioritization of Health Interventions by Incorporating Financial Risk Protection Weights Into Economic Evaluations [Editor's Choice]

    Mar 1, 2023, 00:00

  • Drug Pricing Throughout the Product Lifecycle: A Work in Progress [Editor's Choice]

    Mar 1, 2023, 00:00

  • Use of Structured Template and Reporting Tool for Real-World Evidence for Critical Appraisal of the Quality of Reporting of Real-World Evidence Studies: A Systematic Review

    Mar 1, 2023, 00:00

  • Cost-Effectiveness of First-Line Pembrolizumab Monotherapy Versus Chemotherapy in High Programmed Death-Ligand 1 Advanced Non–Small Cell Lung Cancer in the Irish Healthcare Setting

    Mar 1, 2023, 00:00

  • Table of Contents

    Mar 1, 2023, 00:00

  • Medicare Drug Price Negotiation in the United States: Implications and Unanswered Questions [Editor's Choice]

    Mar 1, 2023, 00:00

  • Measuring Health and Well-Being: We Need to Get it Right for Patients, With Patients

    Mar 1, 2023, 00:00

  • Value-Based Pricing for Patent-Protected Medicines Over the Product Life Cycle: Pricing Anomalies in the “Age of Cures” and Their Implications for Dynamic Efficiency [Editor's Choice]

    Mar 1, 2023, 00:00

  • Author Reply

    Mar 1, 2023, 00:00

  • Modeling Tiered Pricing Frameworks: A Simulation Approach

    Mar 1, 2023, 00:00

  • The Influence of US Drug Price Dynamics on Cost-Effectiveness Analyses of Biologics

    Mar 1, 2023, 00:00

  • The Zero-Price Conundrum: Exploration of Scenarios Where a Clinically Effective New Drug Might Not Be Cost-Effective at Zero Price

    Mar 1, 2023, 00:00

  • Copyright/Subscription

    Mar 1, 2023, 00:00

  • How Much Does the US Public Value Equity in Health? A Systematic Review

    Mar 1, 2023, 00:00

  • Innovative Public Price Mechanisms for Market Access of Innovative Medicines: A Marriage Between Cost-Effectiveness, Medical Need, and Budget Impact

    Mar 1, 2023, 00:00

  • The Impact on Cost-Effectiveness of Accounting for Generic Drug Pricing: Four Case Studies [Editor's Choice]

    Mar 1, 2023, 00:00

  • Does the United States Need Better Policies Governing Generic Drug Use?

    Mar 1, 2023, 00:00

  • The “Affordable Medicines” Reimbursement Program in Ukraine: Framework Assessment and Impact Evaluation

    Mar 1, 2023, 00:00

  • Using Multiple Authorized Generics to Maintain High Prices: The Example of Entacapone

    Mar 1, 2023, 00:00

  • The Allocation of the Economic Value of Second-Generation Antipsychotics Over the Product Life Cycle: The Case of Risperidone in Sweden and the United Kingdom

    Mar 1, 2023, 00:00

  • Editorial Board

    Feb 7, 2023, 10:35

  • Cost-Effectiveness Analysis of Vaccination With Recombinant Zoster Vaccine Among Hematopoietic Cell Transplant Recipients and Persons With Other Immunocompromising Conditions Aged 19 to 49 Years

    Feb 1, 2023, 00:00

  • Preferences for Sexually Transmitted Infection and Cancer Vaccines in the United States and in China

    Feb 1, 2023, 00:00

  • Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib [Editor's Choice]

    Feb 1, 2023, 00:00

  • Table of Contents

    Feb 1, 2023, 00:00

  • Modifying the Composite Time Trade-Off Method to Improve Its Discriminatory Power

    Feb 1, 2023, 00:00

  • Can Observational Analyses of Routinely Collected Data Emulate Randomized Trials? Design and Feasibility of the Observational Patient Evidence for Regulatory Approval Science and Understanding Disease Project

    Feb 1, 2023, 00:00

  • The Impact of Sharing Drug Rebates at the Point of Sale on Out-of-Pocket Payments for Enrollees in Employer-Sponsored Insurance

    Feb 1, 2023, 00:00

  • A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health: A Good Practices Report of an ISPOR Task Force [Editor's Choice]

    Feb 1, 2023, 00:00

  • Disease-Related Loss to Government Funding: Longitudinal Analysis of Individual-Level Health and Tax Data for an Entire Country

    Feb 1, 2023, 00:00

  • Quality-Adjusted Life Expectancy Norms for the English Population [Editor's Choice]

    Feb 1, 2023, 00:00

  • Navigating Patient-Preference Studies for Cross-Stakeholder Decision Making: A Roadmap Guides the Way

    Feb 1, 2023, 00:00

  • A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies

    Feb 1, 2023, 00:00

  • A Scoping Review of the Use of Machine Learning in Health Economics and Outcomes Research: Part 1—Data From Wearable Devices [Editor's Choice]

    Feb 1, 2023, 00:00

  • The Impact of Funding Inpatient Treatments for COVID-19 on Health Equity in the United States: A Distributional Cost-Effectiveness Analysis

    Feb 1, 2023, 00:00

  • Generic Health-Related Quality of Life Utility Measure for Preschool Children (Health Utilities Preschool): Design, Development, and Properties

    Feb 1, 2023, 00:00

  • Is Intention to Treat Still the Gold Standard or Should Health Technology Assessment Agencies Embrace a Broader Estimands Framework? [Editor's Choice]

    Feb 1, 2023, 00:00

  • Copyright/Subscription

    Feb 1, 2023, 00:00

  • The Prader-Willi Syndrome Anxiousness and Distress Behaviors Questionnaire: Development and Psychometric Validation

    Feb 1, 2023, 00:00

  • Comprehensive Score for Financial Toxicity and Health-Related Quality of Life in Patients With Cancer and Survivors: A Systematic Review and Meta-Analysis

    Feb 1, 2023, 00:00

  • Gradient Boosted Tree Approaches for Mapping European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Onto 5-Level Version of EQ-5D Index for Patients With Cancer

    Feb 1, 2023, 00:00

  • Editorial Board

    Jan 9, 2023, 08:36

  • Distributional Cost-Effectiveness Analysis of Health Technologies: Data Requirements and Challenges [Editor's Choice]

    Jan 1, 2023, 00:00

  • Heterogeneous Preferences for Colorectal Cancer Screening in Germany: Results of a Discrete Choice Experiment

    Jan 1, 2023, 00:00

  • Patient-Reported Satisfaction, Experiences, and Preferences: Same but Different? [Editor's Choice]

    Jan 1, 2023, 00:00

  • Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer

    Jan 1, 2023, 00:00

  • Valuing Health Gain from Composite Response Endpoints for Multisystem Diseases

    Jan 1, 2023, 00:00

  • Challenges for Economic Evaluations of Advanced Therapy Medicinal Products: A Systematic Review [Editor's Choice]

    Jan 1, 2023, 00:00

  • Patient and Caregiver Experience Decision Factors in Treatment Decision Making: Results of a Systematic Literature Review of Multiple Myeloma Decision Aids

    Jan 1, 2023, 00:00

  • Enhancing Patient Centricity of Real-World Data Research: An Exploratory Analysis Using the Patient Experience Mapping Toolbox

    Jan 1, 2023, 00:00

  • Assessment of the Social Security Administration Death Master File for Comparative Analysis Studies of Peripheral Vascular Devices

    Jan 1, 2023, 00:00

  • Patient Expectations About Palliative Treatment for Symptomatic Spinal Metastases: A Qualitative Study

    Jan 1, 2023, 00:00

  • Cost-Effectiveness of a Specialized Breathlessness Service Versus Usual Care for Patients With Advanced Diseases

    Jan 1, 2023, 00:00

  • For Me or for My Relatives? Approximating Self-Protection and Local Altruistic Motivations Underlying Preferences for Public Health Policies Using Risk Perception Metrics

    Jan 1, 2023, 00:00

  • A Data-Driven Approach to Support the Understanding and Improvement of Patients’ Journeys: A Case Study Using Electronic Health Records of an Emergency Department

    Jan 1, 2023, 00:00

  • Test-Retest Reliability of EQ-5D-Y-3L Best-Worst Scaling Choices of Adolescents and Adults

    Jan 1, 2023, 00:00

  • The Effect of the Drug Life Cycle Price on Cost-Effectiveness: Case Studies Using Real-World Pricing Data [Editor's Choice]

    Jan 1, 2023, 00:00

  • Table of Contents

    Jan 1, 2023, 00:00

  • Developing Patient-Centered Real-World Evidence: Emerging Methods Recommendations From a Consensus Process

    Jan 1, 2023, 00:00

  • Matching-Adjusted Indirect Comparisons of Lorlatinib Versus Chemotherapy for Patients With Second-Line or Later Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer

    Jan 1, 2023, 00:00

  • Copyright/Subscription

    Jan 1, 2023, 00:00

  • Measuring, Analyzing, and Presenting Work Productivity Loss in Randomized Controlled Trials: A Scoping Review

    Jan 1, 2023, 00:00

  • CO117 Assessing the Impact of Hospital Characteristics on Outcomes of Outpatient Cardiac Procedures: An Analysis of the HCUP-NASS 2019 Database

    Dec 14, 2022, 09:50

  • EPH59 Physicians’ Preferences for the Medical Management of Subarachnoid Hemorrhage Post Aneurysm Repair

    Dec 1, 2022, 00:00

  • PCR210 Quality of Life and Productivity Losses of Dysmenorrhea Patients in Korea

    Dec 1, 2022, 00:00

  • MSR21 Exploration of the Impact of the Treatment Mechanism of Action on the Surrogate Relationship Between Progression Free Survival and Overall Survival in Metastatic Colorectal Cancer

    Dec 1, 2022, 00:00

  • HTA154 Comparing Non-Oncological Rare Condition Submissions to the National Institute for Health and Care Excellence (NICE) Versus Scottish Medicines Consortium (SMC) From 2001 to 2021

    Dec 1, 2022, 00:00

  • EPH112 Assessment of Consumption of Antidepressants in Ukraine Compared With Estonia

    Dec 1, 2022, 00:00

  • EE248 Cost Effectiveness of Novel Antiobiotic Imipenem/Cilastatin/Relebactam in Gram Negative Infections in Greece

    Dec 1, 2022, 00:00

  • HPR106 The Challenges of Outcomes-Based Reimbursement for Advanced Therapy Medicinal Products in Europe

    Dec 1, 2022, 00:00

  • EE454 A Distributional Cost-Effectiveness Analysis of Screening Strategies for Ovarian Cancer

    Dec 1, 2022, 00:00

  • PCR108 Using the Medication Adherence Reasons Scale (MAR-SCALE) in Asthma and Chronic Obstructive Pulmonary Disease to Identify and Describe Reasons for Non-Adherence in 5 European Countries

    Dec 1, 2022, 00:00

  • PCR32 Self-Reported Prevalence and Impact of Clinical Signs, Symptoms, and Events in Adults With Osteogenesis Imperfecta (OI)

    Dec 1, 2022, 00:00

  • EE383 The Economic Burden of COVID-19 Prevention and Cases Management in Egypt from Governmental Perspective

    Dec 1, 2022, 00:00

  • P19 How Is Real-World Evidence Really Being Used in Health Technology Assessments – A Canadian Case Study

    Dec 1, 2022, 00:00

  • HPR32 The Payers’ and Clinicians' Approach to Burden of Disease and Unmet Health Need in a Rare Disease in Poland, Greece, and the Czech Republic - Similarities and Differences

    Dec 1, 2022, 00:00

  • EPH182 Inpatient Burden of Respiratory Syncytial Virus in Children ≤2 Years of Age in Germany: A Retrospective Analysis of Nationwide Hospitalization Data, 2019-2021

    Dec 1, 2022, 00:00

  • CO29 The Very Long-Term Durability of TEVAR for Traumatic Aortic Transection Determined by Real-World Evidence

    Dec 1, 2022, 00:00

  • MSR54 A Comparison of MAIC and STC Methods to Support the Decision at Feasibility Assessment Stage

    Dec 1, 2022, 00:00

  • EE410 Examining the Cost-Effectiveness of Biomarker Testing in Oncology Studies: Should the Health Systems Invest in It?

    Dec 1, 2022, 00:00

  • MT31 A Novel Medical Technology for Rapid Molecular Diagnostics (Nicking Enzyme Amplification Reaction [NEAR]) - A Systematic Literature Review, Meta-Analysis

    Dec 1, 2022, 00:00

  • MSR29 Benchmarking Current Practices in Data Visualisation in HEOR, Identifying Gaps and Suggesting Improvements

    Dec 1, 2022, 00:00

  • CO146 Potential Predictors Affecting Access to Breast Cancer Screening Among Women in the United States Using the Health Behavioral Model: A MEPS Panel Analysis

    Dec 1, 2022, 00:00

  • MT35 The Economic and Capacity Impact of Time Saved in the Operating Theatre Performing Holmium Laser Enucleation of the Prostate with Moses™ Technology vs Standard Technology

    Dec 1, 2022, 00:00

  • EE457 Forecasting Social Welfare GainsFfrom Biosimilar Entries in the Basal Insulin Market

    Dec 1, 2022, 00:00

  • EE170 Cost-Effectiveness of a Digital Diabetes Prevention Program (DDPP) in Prediabetic Patients

    Dec 1, 2022, 00:00

  • HPR159 Neovascular Age-Related Macular Degeneration (NAMD) in Italy: A Social Cost Analysis

    Dec 1, 2022, 00:00

  • HPR117 Meta-Indicators for Analysing Pharmaceutical Systems: The PPRI Indicators

    Dec 1, 2022, 00:00

  • EPH29 The Cost of Managing Safety Events: Ozanimod Versus Tofacitinib – A UK Perspective

    Dec 1, 2022, 00:00

  • EE521 Comparing the Cohort and Micro-Simulation Modeling Approaches in Cost-Effectiveness Modeling of Bone Conduction Implants (BCI): A Case Study of a Longitudinal Economic Analysis and a Markov Model-Based Simulation.

    Dec 1, 2022, 00:00

  • EE121 Cost-Effectiveness of Family Based Treatment for Pediatric Obesity: A Literature Review

    Dec 1, 2022, 00:00

  • RWD154 Clinical Characteristics and Pathways of Care of Breast Cancer Patients Receiving Targeted Therapy in Hungary

    Dec 1, 2022, 00:00

  • HTA175 Health Technology Assessment Decisions in Sweden and Denmark: A Comparative Study in Understanding the Challenges of Approval for Single-Arm Trials

    Dec 1, 2022, 00:00

  • EPH89 Epidemiology of Myxoid Round Cell Liposarcoma (MRCLS) in the European Union (EU27) – An Extrapolation From the United States (US) Surveillance, Epidemiology, and End Results (SEER) Research Database

    Dec 1, 2022, 00:00

  • EE385 Cost Effectiveness of Gender-Neutral Vaccination With Gardasil 9 Against HPV in Greece

    Dec 1, 2022, 00:00

  • The Use of Generic Patient-Reported Outcome Measures in Emergency Department Surveys: Discriminant Validity Evidence for the Veterans RAND 12-Item Health Survey and the EQ-5D

    Dec 1, 2022, 00:00

  • HSD68 Barriers and Facilitators of Shared Decision Making in Clinical Practi An Umbrella Review

    Dec 1, 2022, 00:00

  • HSD61 Trends in Discontinuation of Lipid-Lowering and Antihypertensive Therapies: A Real-World Data Analysis in Italy

    Dec 1, 2022, 00:00

  • HTA114 Review of Health Technology Assessment (HTA) and Recommendations for the Introduction of Higher-Valency Pneumococcal Conjugated Vaccine (PCV) in 4 European Countries, The United-Kingdom (UK), and The United-States (US)

    Dec 1, 2022, 00:00

  • EE172 The Wisdom Self-Management Intervention: A Cost-Effectiveness Analysis to Support the Transformation of Type 2 Diabetes Care in England

    Dec 1, 2022, 00:00

  • MSR97 Systematic Literature Review of the Efficacy and Safety of Pharmacological Treatments and Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy

    Dec 1, 2022, 00:00

  • HPR161 A Long-Term Forecast of the Economic Impact of Gene Therapies in France

    Dec 1, 2022, 00:00

  • HPR67 Identifying the Key Challenges in the Reimbursement of Next Generation Sequencing and Future Policy Changes in Europe Using a Web-Based Portal to Engage Payers

    Dec 1, 2022, 00:00

  • MSR120 To Include an Error Once May Be Regarded as a Misfortune, to Include It Again Looks Like Carelessness

    Dec 1, 2022, 00:00

  • EE343 Assessing Impact of Kidney Cancer-Related Premature Mortality and Productivity Loss in Greece and Portugal

    Dec 1, 2022, 00:00

  • PCR233 The Case Studies of an Integrative Approach in Primary Healthcare of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Post-COVID-19 Patients

    Dec 1, 2022, 00:00

  • HTA90 Use of General Population Utilities in NICE Highly Specialised Technology Appraisals of Treatments With the Potential to Restore Normal Physiology

    Dec 1, 2022, 00:00

  • CO26 Types of the Most Frequent Provider of Ambulatory Diabetes Care and Its Impact on Continuity of Care, Medical Expenses Using National Health Insurance Database of Korea

    Dec 1, 2022, 00:00

  • PCR101 Understanding the Burden of Disease for Pediatric and Adult Patients With Classic Galactosemia: A Survey and Interview Study

    Dec 1, 2022, 00:00

  • HPR48 Reimbursement Policies Regarding Rare Diseases in Central and Eastern European Countries

    Dec 1, 2022, 00:00

  • PCR269 People and Families Affected by Gsdia: An Analysis of Narrative Accounts Written by Caregivers and Individuals Living With GSDIa

    Dec 1, 2022, 00:00

  • HTA113 Accounting for Caregiver Quality of Life in Cost-Effectiveness Analyses of Rare Genetic Disease of Obesity – A Case Study in the Swedish Context

    Dec 1, 2022, 00:00

  • EE154 Reassessment of a Cost-Effectiveness Analysis of Etonogestrel Implant Compared to Other Contraceptive Methods Based on Real Life Data in France

    Dec 1, 2022, 00:00

  • PCR185 The Role of Patients’ Advocacy Groups in the Italian Health Care Ecosystem: Present and Future Perspectives

    Dec 1, 2022, 00:00

  • PCR225 Quality of Life (QOL)-Related Mentions for Prevalent Diseases on Social Media Platforms in the US

    Dec 1, 2022, 00:00

  • EPH173 Current Issues and Expected Challenges in Identification of Depression as a Cardinal Symptom Within Bipolar Disorder

    Dec 1, 2022, 00:00

  • EE287 Indirect Costs of Multiple Myeloma in Portugal

    Dec 1, 2022, 00:00

  • PCR292 Health State Utility Values (HSUVs) and Health-Related Quality of Life (HRQoL) in People Living With HIV/AIDS (PLWH): A Systematic Literature Review (SLR)

    Dec 1, 2022, 00:00

  • HPR69 Evaluation of Availability, Prices and Affordability of Breast Cancer Medicines in Kwara-Central Senatorial District, Nigeria

    Dec 1, 2022, 00:00

  • EPH83 An One-Year Static Cross-Sectional Population Model to Assess the Infection Burden Across the Ageing Population: An Application to the Flemish County

    Dec 1, 2022, 00:00

  • MSR61 Lessons Learned From Network Meta-Analysis of Survival Data With Fractional Polynomials

    Dec 1, 2022, 00:00

  • EPH54 Prevalence and Association of Sociodemographic Determinants With the Risk of Developing Type 2 Diabetes in Saudi Arabia: A Web-Based Cross-Sectional Survey Study

    Dec 1, 2022, 00:00

  • CO45 Real-World Clinical Outcomes of Secukinumab in Thai Patients With Psoriasis: Subgroup Analyses By Adherence Rate and Completeness of Loading Dose

    Dec 1, 2022, 00:00

  • EE141 Cost-Effectiveness of TP53 and IGHV Biomarker Testing Prior to First-Line Treatment With Novel Agents for Chronic Lymphocytic Leukemia

    Dec 1, 2022, 00:00

  • HPR49 Are Countries Using ATC Classification and Defined Daily Dose for Pricing and Reimbursement Decisions of Pharmaceuticals?

    Dec 1, 2022, 00:00

  • EPH157 Physical Activity Level in Association with Mental Health Before and During the Restrictions of the First Three Waves of COVID-19 Pandemic Among Hungarian Adults

    Dec 1, 2022, 00:00

  • MSR112 Evaluating Colombia's Health Insurers Efficiency in Lung Cancer Management: A Data Envelopment Analysis

    Dec 1, 2022, 00:00

  • CO9 Impact of Patient Blood Management (PBM) on the Reduction of Transfusion Requirements and Length of Hospital Stay in Patients Undergoing Major Planned Orthopedic in Germany

    Dec 1, 2022, 00:00

  • RWE Applications in Health Technology Assessment

    Dec 1, 2022, 00:00

  • RWD130 The Effect of the COVID-19 Pandemic in the Prevalence of Diabetes Mellitus Type 1 and 2 in Children and Young Adults in Gree Real World Data from Greece

    Dec 1, 2022, 00:00

  • MSR114 Current Scenario of ‘Scenario Analysis’ in Health Economic Modelling in Oncology: A Review of NICE Appraisals

    Dec 1, 2022, 00:00

  • PCR58 The Use of Argumentation Based Synthesis to Interrogate Evidence to Support Treatment Decisions Reflecting Individual Preferences

    Dec 1, 2022, 00:00

  • HSD89 Early Detection of Breast Cancer in Indonesia: Barriers Identified in a Qualitative Study

    Dec 1, 2022, 00:00

  • EE402 Social and Economic Burden of Breast Cancer in Russia

    Dec 1, 2022, 00:00

  • EE12 Cost of Stroke Management in Turkey

    Dec 1, 2022, 00:00

  • CO2 Long-Term Survival After an Acute Stroke in Brazil From 2012-2021: A Population-Based Cohort Study From a Healthcare Plan

    Dec 1, 2022, 00:00

  • CO99 Does Use of Digital Health Interventions in Diabetes Improve Patient Outcomes? Evidence From a Targeted Literature Review

    Dec 1, 2022, 00:00

  • EE420 Valuation of Lost Productivity for Individuals Diagnosed With Osteogenesis Imperfecta: Follow-up Findings From the Rudy Cohort Study in the UK

    Dec 1, 2022, 00:00

  • EE86 Evaluation of Long- Versus Short-Term Use of Patiromer on Healthcare Resource Utilization in the Patiromer Long-Term Use Evaluation (VALUE) Study

    Dec 1, 2022, 00:00

  • CO107 Clinical Outcomes of Patients With Metastatic Renal Cell Carcinoma (MRCC) With or Without Sarcomatoid Differentiation Treated With Systemic Therapy in Real-World Canadian Setting

    Dec 1, 2022, 00:00

  • EE376 Cost-Effectiveness of Complete Guideline-Adherent Use of Coronary Angiography From the German Payer Perspective

    Dec 1, 2022, 00:00

  • PCR265 Preferences and Needs of Heart Failure Patients Regarding Their Treatment and Care

    Dec 1, 2022, 00:00

  • PCR280 Development of a Patient-Reported Outcome Measure to Evaluate Self-Perception and Psychosocial Impact in Adolescents and Young Adults With Acne

    Dec 1, 2022, 00:00

  • HTA172 External Control Arm Studies in the Context of Pricing and Reimbursement Assessments – Overview on Guidance and Evaluation in Europe

    Dec 1, 2022, 00:00

  • RWD126 Introducing the German MSDS-AOK PLUS Database: Linkage of Administrative Claims Data and a Patient Registry for Advanced RWE Capabilities in Multiple Sclerosis

    Dec 1, 2022, 00:00

  • HTA54 Incorporating Value of Health System Impact in Economic Evaluations of Therapies of Chronic Diseases

    Dec 1, 2022, 00:00

  • EPH30 Disability-Adjusted Life Years Lost Due to Migraine: A Nationwide Burden-of-Illness Study From the National Health Survey in Spain

    Dec 1, 2022, 00:00

  • EPH47 Early Hospital Management of Ageing Disease: Retrospective Study From a National Claims Database

    Dec 1, 2022, 00:00

  • EPH61 Obesity and Glycemic Control Among People With Type 2 Diabetes in Europe: A Retrospective Cohort Analysis

    Dec 1, 2022, 00:00

  • Frameworks and Methods for the Design of Stated Preference

    Dec 1, 2022, 00:00

  • EPH15 Epidemiology of Patients Revascularized for Peripheral Artery Disease in France (2016-19): A Retrospective Observational Cohort Study Using the French Hospital Discharge Database (PMSI)

    Dec 1, 2022, 00:00

  • EPH194 Risk Factors Affecting Caries Development Among Primary School Children

    Dec 1, 2022, 00:00

  • CO7 Evaluating Health Outcomes and Costs Related to In-Hospital Procedures for the Management of Mitral Valve Disease in Spain

    Dec 1, 2022, 00:00

  • MSR15 Using Advanced Parametric Survival Models for HTA Submissions in the Face of Short-Term Patient Follow-Up

    Dec 1, 2022, 00:00
  • «
  • 21
  • 22
  • 23
  • 24
  • 25 (current)
  • 26
  • 27
  • 28
  • 29
  • 30
  • »